Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Hilton Food downgrades FY profit guidance, shares tumble

(Sharecast News) - Hilton Food tumbled on Tuesday as it downgraded its full-year profit guidance and struck a downbeat tone on the outlook for trading in 2026, citing operational disruption and subdued demand. In a third-quarter trading update, the company said underlying demand was "subdued", but the normal seasonal uplift in the fourth quarter was expected to support overall performance in the near term.

It now expects adjusted pre-tax profit for the financial year ending 28 December of between £72m and £75m. This is below company-compiled consensus of £76.8m to £81m in September.

"Given the emerging impact on demand from ongoing inflationary pressures and the continued disruption at Foppen, the board has become more cautious on the trading outlook for 2026 and as such expects profit progression in the next financial year to be difficult," it said.

In the third quarter, Hilton said it maintained "a resilient trading performance amid a highly inflationary pricing environment".

Volumes across red meat and convenience remain solid, with convenience in particular continuing to perform well, although ongoing price inflation pressures continue to weigh on underlying demand, it said.

Hilton said the Foppen smoked salmon business in Europe was still experiencing operational disruption due to regulatory restrictions on shipments to the US, which has resulted in additional costs.

"We have implemented actions to address the issues, but the ongoing US government shutdown has resulted in delay to the approvals for the Greek facility to recommence production," it said. "As a result, we do not expect that production in Greece will resume in 2025."

At 1115 GMT, the shares were down 24.4% at 484.50p.

House broker Shore Capital downgraded its FY26 adjusted pre-tax expectation by around 17% to £67m from £80.5m after the results.

It said: "Visibility is currently low, which rarely benefits an investment thesis, but we feel it is prudent with the outlined moving parts indicated by the firm to take a cautious view with our estimates.

"We are conscious of a number of recent prior reductions to our forecasts, which we know also does not help investor confidence. So, bringing this altogether, we now forecast FY26 EPS of 51.4p, a circa 8% lower EPS YoY. To summarise, our new forecast reflects uncertainty in the core business and the potential for further slippage."

Share this article

Related Sharecast Articles

Derwent sells Horseferry House in London for £132m
(Sharecast News) - Derwent London has exchanged contracts for the disposal of Horseferry House in London for £131.8m to an unnamed overseas investor, the company said on Wednesday.
Babcock inks naval support bridging contract with UK govt
(Sharecast News) - Defence company Babcock International said it had agreed a six-month bridging deal with the UK government to maintain naval base and nuclear submarine fleet support services while a new contract is negotiated.
Berkeley refreshes strategy, reiterates FY26 PBT guidance
(Sharecast News) - Property developer Berkeley Group laid out a refreshed strategy on Wednesday as it looks to navigate what it called a "prolonged challenging market backdrop" marked by higher costs, tighter regulation and ongoing economic uncertainty.
Eli Lilly to buy Centessa Pharmaceuticals for up to $7.8bn
(Sharecast News) - Eli Lilly said on Tuesday that it has agreed to buy Centessa Pharmaceuticals, a clinical-stage company developing a new class of medicines for the treatment of excessive daytime sleepiness, for up to $7.8bn.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.